JP2005518183A - インターフェロンガンマポリペプチド変異体 - Google Patents

インターフェロンガンマポリペプチド変異体 Download PDF

Info

Publication number
JP2005518183A
JP2005518183A JP2002579493A JP2002579493A JP2005518183A JP 2005518183 A JP2005518183 A JP 2005518183A JP 2002579493 A JP2002579493 A JP 2002579493A JP 2002579493 A JP2002579493 A JP 2002579493A JP 2005518183 A JP2005518183 A JP 2005518183A
Authority
JP
Japan
Prior art keywords
seq
variant
polypeptide
ifng
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002579493A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005518183A5 (zh
Inventor
アンネ・ダーム・イェンセン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maxygen Holdings Ltd
Original Assignee
Maxygen Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxygen Holdings Ltd filed Critical Maxygen Holdings Ltd
Publication of JP2005518183A publication Critical patent/JP2005518183A/ja
Publication of JP2005518183A5 publication Critical patent/JP2005518183A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2002579493A 2001-04-06 2002-04-04 インターフェロンガンマポリペプチド変異体 Pending JP2005518183A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200100579 2001-04-06
DKPA200100714 2001-05-07
DKPA200200198 2002-02-11
PCT/DK2002/000226 WO2002081507A2 (en) 2001-04-06 2002-04-04 Interferon gamma polypeptide variants

Publications (2)

Publication Number Publication Date
JP2005518183A true JP2005518183A (ja) 2005-06-23
JP2005518183A5 JP2005518183A5 (zh) 2006-01-05

Family

ID=27222504

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002579493A Pending JP2005518183A (ja) 2001-04-06 2002-04-04 インターフェロンガンマポリペプチド変異体

Country Status (15)

Country Link
EP (1) EP1412382A2 (zh)
JP (1) JP2005518183A (zh)
KR (1) KR20030094336A (zh)
CN (1) CN1257186C (zh)
BG (1) BG108256A (zh)
BR (1) BR0208596A (zh)
CA (1) CA2443277A1 (zh)
HK (1) HK1069834A1 (zh)
HU (1) HUP0303645A3 (zh)
IL (1) IL157896A0 (zh)
MX (1) MXPA03009082A (zh)
NO (1) NO20034432L (zh)
NZ (1) NZ528651A (zh)
PL (1) PL366705A1 (zh)
WO (1) WO2002081507A2 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009060804A (ja) * 2007-09-04 2009-03-26 National Research Inst Of Brewing ピヒア属酵母において異種タンパク質を高分泌させる方法

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2390262A1 (en) 2003-05-16 2011-11-30 Intermune, Inc. Synthetic chemokine receptor ligands and methods of use thereof
JP4707327B2 (ja) * 2004-01-27 2011-06-22 旭化成ファーマ株式会社 ポリペプタイド類の吸着防止剤
KR20070085227A (ko) * 2004-08-09 2007-08-27 앨리오스 바이오파마 인크. 합성 초글리코실화, 프로테아제 저항성 폴리펩티드 변이체,경구 제제 및 이를 이용한 방법
US7597884B2 (en) * 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
CN103550757A (zh) * 2005-09-20 2014-02-05 纽约大学 用干扰素治疗肺病的方法
US7625555B2 (en) 2007-06-18 2009-12-01 Novagen Holding Corporation Recombinant human interferon-like proteins
EP2039764A1 (en) * 2007-09-19 2009-03-25 Pevion Biotech AG Truncated secretory aspartyl proteinase 2
BG66517B1 (bg) 2008-04-08 2016-02-29 Tigo Gmbh Супресор на ендогенния човешки гама - интерферон
RU2446821C2 (ru) * 2010-07-15 2012-04-10 Олег Ильич Эпштейн Лекарственное средство для лечения инфекционных заболеваний, сопровождающихся нейротоксическими нарушениями, и способ лечения инфекционных заболеваний, сопровождающихся нейротоксическими нарушениями
GB201621728D0 (en) 2016-12-20 2017-02-01 Ucb Biopharma Sprl Methods
BG67190B1 (bg) 2017-03-29 2020-11-16 Tigo Gmbh Анти-гама мутантен протеин срещу ендогенния човешки гама интерферон
WO2023182947A1 (en) * 2022-03-22 2023-09-28 Chiang Mai University A modified protein of interferon gamma and its use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
BG52073B2 (en) * 1990-01-24 1996-04-30 Inst Molekuljarna Biolog Method for the preparation of recombinant human noncystein -interferon, free of n-end methionine
DE4036856C1 (zh) * 1990-11-19 1992-05-27 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung Ev, 8000 Muenchen, De

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009060804A (ja) * 2007-09-04 2009-03-26 National Research Inst Of Brewing ピヒア属酵母において異種タンパク質を高分泌させる方法

Also Published As

Publication number Publication date
CN1257186C (zh) 2006-05-24
NO20034432L (no) 2003-10-29
CA2443277A1 (en) 2002-10-17
BG108256A (bg) 2004-12-30
HK1069834A1 (en) 2005-06-03
HUP0303645A3 (en) 2005-12-28
MXPA03009082A (es) 2004-11-22
WO2002081507A2 (en) 2002-10-17
BR0208596A (pt) 2004-03-09
PL366705A1 (en) 2005-02-07
IL157896A0 (en) 2004-03-28
NO20034432D0 (no) 2003-10-03
WO2002081507A3 (en) 2004-02-12
EP1412382A2 (en) 2004-04-28
HUP0303645A2 (hu) 2004-01-28
NZ528651A (en) 2006-06-30
CN1537117A (zh) 2004-10-13
KR20030094336A (ko) 2003-12-11

Similar Documents

Publication Publication Date Title
US7504237B2 (en) Polynucleotides encoding interferon gamma polypeptides
US7419805B2 (en) Polynucleotides encoding S99T interferon gamma polypeptide variants and means of expression
JP2004534523A (ja) 新規なインターフェロンβ様分子
US7390638B2 (en) S99T C-11 Truncated polynucleotides encoding interferon gamma polypeptide variants
US7230081B1 (en) Interferon gamma conjugates
JP2005518183A (ja) インターフェロンガンマポリペプチド変異体
EP1257574A1 (en) Improved interleukin 10
US7524931B2 (en) Full-length interferon gamma polypeptide variants
RU2268749C2 (ru) КОНЪЮГАТЫ γ-ИНТЕРФЕРОНА
RU2296130C2 (ru) Варианты полипептида гамма-интерферона
AU2002252971B2 (en) Interferon gamma polypeptide variants
AU782635B2 (en) Interferon gamma conjugates
ZA200308376B (en) Interferon gamma polypeptide variants.
AU2002252971A1 (en) Interferon gamma polypeptide variants
CZ20033016A3 (cs) Varianty polpeptidu interferonu gamma

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050404

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050404

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080408

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20080911

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090714

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100105